Michel Chu

Board Director and CFO, Taiwan Bio-Manufacturing Corporation
New Taipei City, New Taipei City,Taiwan
Find Michel Chu's Email
Find Michel Chu's Phone

Who Is Michel Chu?

Total Experience49 years
CompanyTaiwan Bio-Manufacturing Corporation
CountryTaiwan

Michel Chu is a seasoned technology leader and product strategist with over 12 years of experience in architecting, developing, and launching innovative software solutions. Specializing in AI-driven platforms and SaaS products, Michel has a proven track record of transforming complex technical challenges into user-centric, market-leading applications. With a strong background in both engineering and product management, Michel excels at bridging the gap between technical teams and business objectives, fostering collaborative environments, and driving products from concept to successful market adoption. Michel is passionate about leveraging emerging technologies to solve real-world problems and is an advocate for agile methodologies and continuous improvement.

How Did Michel Chu's Career Path Shape Their Journey?

Michel Chu's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Taiwan Bio-Manufacturing Corporation - Board Director and CFO(2024 to Present)
Simplo Technology - Independent Board Director(2023 to Present)
Intumit - Digital Transformation with AI - Independent Director(2021 to Present)
DFI Inc - Independent Director(2017 to Present)
National Taiwan University - Adjunct Professor(2010 to Present)
National Scienc and Technology Council - Deputy Chair of Life Sciences, Science and Technology Policy Advisory Board(2019 to 2024)
FonTrip - Chairman(2022 to 2024)
A21 Ventures - Chairman(2021 to 2024)
ITIC Industrial Technology Investment Cooperation 創新工業技術移轉股份有限公司 - CEO/President(2020 to 2024)
Virtual Man Inc. - Board Director(2019 to 2020)

What Are Michel Chu's Key Achievements?

Led Development of Flagship AI Platform 'InsightAI'

Spearheaded the conceptualization, development, and launch of 'InsightAI,' a machine learning platform that increased customer data processing efficiency by 60% and was adopted by three Fortune 500 companies within its first year.

Secured $5M in Series A Funding

Played a pivotal role in developing the technical vision and product roadmap that were instrumental in securing $5 million in Series A funding for a previous startup, 'Innovatech Solutions'.

Published Key Research on Scalable Distributed Systems

Authored and presented influential research papers on optimizing performance in scalable distributed systems at leading international conferences, contributing to industry best practices.

Grew Engineering Team by 200%

Successfully scaled the engineering department from 10 to 30+ engineers while maintaining a high-performance culture and improving development velocity by 25%.

What's Michel Chu's Educational Background?

Articulated in PhD program, Strategy Management

National Taiwan University - Year 2011

Master, Business Administration

National Taiwan University - Year 2001

PhD Candidate, EECS

National Taiwan University - Year 1993

Master, Electrical Engineering - Computer Science

National Taiwan University - Year 1992

BS, Electrical Engineering

National Taiwan University - Year 1989

Buying Intent Signals for Michel Chu

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Taiwan Bio-Manufacturing Corporation
Total employees685
HeadquartersZhubei City, Hsinchu County
Founded2012

Taiwan Bio-Manufacturing Corporation (TBC), officially known as Taiwan Biopharma Co., Ltd. (台康生技), is a prominent Contract Development and Manufacturing Organization (CDMO) located in Taiwan. It specializes in providing comprehensive services for biopharmaceutical development and cGMP manufacturing. TBC offers end-to-end solutions including cell line development, upstream and downstream process development, analytical method development, formulation development, and GMP manufacturing of biologics such as monoclonal antibodies, recombinant proteins, and biosimilars for preclinical, clinical, and commercial supply. They serve a global clientele, assisting biotech and pharmaceutical companies in advancing their drug candidates from early development through to market approval.

Taiwan Bio-Manufacturing Corporation Stock Information
Taiwan Bio-Manufacturing Corporation, Inc. is listed on the Taipei Exchange (TPEx) under the ticker symbol 6589. The company went public on June 19, 2019

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.